Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
131,900
Employees131,900
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
131,900
Employees131,900

JNJ Key Statistics

Market cap
377.62B
Market cap377.62B
Price-Earnings ratio
28.58
Price-Earnings ratio28.58
Dividend yield
3.01%
Dividend yield3.01%
Average volume
7.02M
Average volume7.02M
High today
$158.67
High today$158.67
Low today
$156.51
Low today$156.51
Open price
$158.60
Open price$158.60
Volume
6.60M
Volume6.60M
52 Week high
$175.97
52 Week high$175.97
52 Week low
$144.95
52 Week low$144.95

JNJ News

Barron's 10h
Nvidia Is Teaming Up with J&J MedTech to Advance AI Surgery

Nvidia said Monday that it was partnering with Johnson & Johnson MedTech to use the power of AI to help doctors perform surgery. J&J MedTech is in 80% of the wo...

Nvidia Is Teaming Up with J&J MedTech to Advance AI Surgery
CNBC 10h
Nvidia and Johnson & Johnson to develop new AI applications for surgery - CNBC

Johnson & Johnson on Monday announced it is working with Nvidia to develop and scale new artificial intelligence applications for surgery. J&J's MedTech unit a...

Nvidia and Johnson & Johnson to develop new AI applications for surgery - CNBC
Yahoo Finance 10h
Johnson & Johnson Stock Dips While Market Gains: Key Facts - Yahoo Finance

Johnson & Johnson (JNJ) closed at $156.76 in the latest trading session, marking a -0.9% move from the prior day. The stock's performance was behind the S&P 500...

Johnson & Johnson Stock Dips While Market Gains: Key Facts - Yahoo Finance

Analyst ratings

57%

of 23 ratings
Buy
43.5%
Hold
56.5%
Sell
0%

More JNJ News

Yahoo Finance 19h
Johnson & Johnson is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the s...

Johnson & Johnson is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Simply Wall St 2d
Insiders At Johnson & Johnson Sold US$6.8m In Stock, Alluding To Potential Weakness

Over the past year, many Johnson & Johnson (NYSE:JNJ) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whethe...

Insiders At Johnson & Johnson Sold US$6.8m In Stock, Alluding To Potential Weakness
Yahoo Finance 3d
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. - Yahoo Finance

Johnson & Johnson (NYSE: JNJ) is one of the leading and most recognizable names in healthcare. It generates billions in revenue and profit every year and its pr...

Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. - Yahoo Finance
TipRanks 4d
J&J says ODAC recommends Carvykti for earlier treatment of myeloma

Johnson & Johnson announced that the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee, or ODAC, recommends Carvykti for the treatment of adu...

Benzinga 4d
Bristol Myers' Breyanzi Scores Second FDA Approval For Blood Cancers Therapy

Loading... Loading... The FDA granted accelerated approval on Thursday to Bristol Myers Squibb Co.’s BMY of Breyanzi (lisocabtagene maraleucel, liso-cel), a CD...

Bristol Myers' Breyanzi Scores Second FDA Approval For Blood Cancers Therapy
TipRanks 4d
FDA advisors vote in favor of expanding label of J&J’s Carvykti

An FDA advisory committee voted 11-0 in favor of expanding the label of Carvykti, finding that the benefits of the Johnson & Johnson treatment outweigh risks in...

Yahoo Finance 5d
The Zacks Analyst Blog Highlights UnitedHealth Johnson & Johnson, Oracle, Wells Fargo & Co and Caterpillar. - Yahoo Finance

For Immediate Release Chicago, IL – March 14, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...

The Zacks Analyst Blog Highlights UnitedHealth Johnson & Johnson, Oracle, Wells Fargo & Co and Caterpillar. - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.